<SEC-DOCUMENT>0001193125-21-079591.txt : 20210609
<SEC-HEADER>0001193125-21-079591.hdr.sgml : 20210609
<ACCEPTANCE-DATETIME>20210312155532
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-21-079591
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20210312

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Global-E Online Ltd.
		CENTRAL INDEX KEY:			0001835963
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		25 BASEL STREET
		CITY:			PETAH
		STATE:			L3
		ZIP:			4951038
		BUSINESS PHONE:		646 503 1290

	MAIL ADDRESS:	
		STREET 1:		25 BASEL STREET
		CITY:			PETAH
		STATE:			L3
		ZIP:			4951038
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">53rd at Third</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ROWSPAN="6"> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g77487dsp01.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">885 Third Avenue</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">New York, New York 10022-4834</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Tel: +1.212.906.1200 Fax: +1.212.751.4864</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">www.lw.com</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">FIRM / AFFILIATE OFFICES</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Beijing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Moscow</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Boston</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Munich</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Brussels</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">New York</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Century City</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Orange County</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chicago</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paris</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Dubai</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Riyadh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><U>FOIA CONFIDENTIAL TREATMENT REQUEST UNDER 17 C.F.R. &#167;200.83</U></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">D&uuml;sseldorf</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">San Diego</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Frankfurt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">San Francisco</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Hamburg</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Seoul</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Hong Kong</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Shanghai</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Houston</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Silicon Valley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The entity requesting confidential treatment is:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">London</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Singapore</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Los Angeles</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tokyo</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="white-space:nowrap">Global-E</FONT> Online Ltd.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Madrid</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Washington,&nbsp;D.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">25 Basel Street</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Milan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Petah Tikva 4951038, Israel</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain confidential information in this letter has been omitted and provided separately to the Securities and Exchange
Commission. Confidential treatment has been requested by Global-E Online Ltd. with respect to the omitted portions, which are identified in this letter by the mark &#147;[***].&#148; </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 12, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>VIA EDGAR and COURIER DELIVERY
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of
Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Office of Technology </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, N.E.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attention:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Ryan Rohn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stephen Krikorian</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Matthew Crispino</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Larry Spirgel</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Global-E</FONT> Online Ltd. | Anticipated Price Range
</B></P></TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> (File No. 333-253999) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sir or Madam: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This supplemental letter is
being furnished on behalf of <FONT STYLE="white-space:nowrap">Global-E</FONT> Online Ltd. (the &#147;<B><I>Company</I></B>&#148;) in connection with the review by the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) of
the above-mentioned Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> (the &#147;<B><I>Registration Statement</I></B>&#148;). Because of the commercially sensitive nature of the information contained herein, this submission
is accompanied by the Company&#146;s request for confidential treatment of selected portions of this letter pursuant to Rule 83 of the Commission&#146;s Rules on Information and Requests, 17 C.F.R &#167;200.83. A redacted letter has been filed on
EDGAR, omitting the confidential information contained in this letter. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIAL TREATMENT HAS BEEN REQUESTED BY GLOBAL-E ONLINE LTD. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>March </B><B>12</B><B>, 2021</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Page </B><B>
2</B>
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g77487dsp02.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To assist the staff (the &#147;<B><I>Staff</I></B>&#148;) of the Commission in its review,
the Company advises the Staff that, although not yet reflected in the Registration Statement, based on discussions with the Company&#146;s Board of Directors (the &#147;<B><I>Board of Directors</I></B>&#148;) and reflecting the input from the lead
underwriters, the Company currently anticipates an approximate price range of $[***] to $[***] per share for the Company&#146;s ordinary shares (the &#147;<B><I>Preliminary Price Range</I></B>&#148;) with a midpoint of the anticipated range of
approximately $[***] per share (the &#147;<B><I>Preliminary Assumed IPO Price</I></B>&#148;). The Preliminary Price Range and Preliminary Assumed IPO Price do not reflect a split of the Company&#146;s ordinary shares that the Company presently
intends to effect prior to the Commission&#146;s declaration of effectiveness of the Registration Statement (the &#147;<B><I>Stock Split</I></B>&#148;)<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>. The Company advises the Staff a <FONT
STYLE="white-space:nowrap">pre-effective</FONT> amendment to the Registration Statement, after giving effect to the Stock-Split, will include a price range of no more than $2.00, if the maximum price is $10.00 per share or less, or 20%, if the
maximum price is greater than $10.00 per share, unless otherwise approved by the Staff. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s final post-Stock Split
Preliminary Price Range remains under discussion between the Company and the Underwriters, and a bona fide price range will be included in an amendment to the Registration Statement prior to any distribution of the preliminary prospectus in
connection with the Company&#146;s road show. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Analysis of Option Grants Since September&nbsp;1, 2020 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes by grant date the number of ordinary shares underlying stock options granted since September&nbsp;1, 2020, as
well as the exercise price per share and the estimated fair value per share of the Company&#146;s ordinary shares on the date of option grant (the below does not reflect the contemplated Stock Split). </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Grant Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>Underlying&nbsp;Options<BR>Granted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share&nbsp;Exercise<BR>Price of Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated&nbsp;Fair&nbsp;Value<BR>of Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October&nbsp;21, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,061.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,110.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;10, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,123.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,339.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Ordinary Shares Valuation Methodologies </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described in the Registration Statement, the Company has historically determined the fair value of its ordinary shares using methodologies,
approaches and assumptions consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide, <I>Valuation of Privately-Held-Company Equity Securities Issued as Compensation </I>(the &#147;<B><I>AICPA Practice
Guide</I></B>&#148;). The Board of Directors has estimated the fair value of the Company&#146;s ordinary shares at various grant dates, with input from management, considering the Company&#146;s most recently available third-party valuations of the
ordinary shares and the Board of Director&#146;s </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company advises the staff that it presently intends to effect a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">[***]-for-[***]</FONT></FONT> split of the Company&#146;s ordinary shares prior to effectiveness of the Registration Statement. The final ratio remains under discussion, and will be reflected in an amendment to the
Registration Statement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED BY </B><B>GLOBAL-E ONLINE LTD</B><B>.</B> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>March </B><B>12</B><B>, 2021</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Page </B><B>
3</B>
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g77487dsp02.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">assessment of various objective and subjective factors, to determine the fair value of the Company&#146;s
ordinary shares as further disclosed within the section of the Registration Statement titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Application of Critical Accounting Policies and
Estimates&#151;Ordinary Shares Valuations,&#148; which is included on pages 85 and 86 of the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In valuing the
Company&#146;s ordinary shares, the Company used the original issue price of the Convertible Preferred E shares issued in April 2020 (the &#147;<B><I>Series E Financing</I></B>&#148;) as an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT>
fair value of the Company&#146;s business, or equity value. The Series E Financing was a financing transaction led by third-party investors, in which the Company sold Series E convertible preferred stock at a price of $2,498.65 per share raising net
proceeds of $59.3&nbsp;million, which price per share was determined in negotiations with such investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The resulting equity value was
then allocated to each share using an Option Pricing Model (&#147;<B><I>OPM</I></B>&#148;). The OPM allocates the overall company value to the various share classes based on differences in liquidation preferences, participation rights, dividend
policy, and conversion rights, using a series of call options. The OPM is appropriate to use when the range of possible future outcomes is difficult to predict. Beginning in April 2020, the Company utilized a probability-weighted expected return
method (&#147;<B><I>PWERM</I></B>&#148;) to allocate value among the various share classes. The PWERM involves the estimation of the value of the Company under multiple future potential outcomes and estimates the probability of each potential
outcome. The <FONT STYLE="white-space:nowrap">per-share</FONT> value of the Company&#146;s ordinary shares as determined through the PWERM was ultimately based upon probability-weighted per share values resulting from the various future scenarios,
which include an initial public offering or continued operation as a private company. After the ordinary share value was determined, a discount for lack of marketability (&#147;<B><I>DLOM</I></B>&#148;) was applied to arrive at the fair value of the
ordinary shares on a <FONT STYLE="white-space:nowrap">non-marketable</FONT> basis. A DLOM is applied in order to reflect the lack of a recognized market for a closely held interest and the fact that a
<FONT STYLE="white-space:nowrap">non-controlling</FONT> equity interest may not be readily transferable. A market participant purchasing this stock would recognize this illiquidity associated with the shares, which would reduce the overall fair
market value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Discussion of Fair Value Determinations and Option Grants Since September&nbsp;1, 2020. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I><U>April 2020 Valuation </U> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A valuation was performed by the Company with the assistance of a third-party independent valuation firm that determined the fair value of the
Company&#146;s ordinary shares to be $1,268.24 per share as of April&nbsp;20, 2020 (the &#147;<B><I>April 2020 Valuation</I></B>&#148;). The April 2020 Valuation estimated the ordinary share value using a PWERM that considered (i)&nbsp;a <FONT
STYLE="white-space:nowrap">non-IPO</FONT> scenario using an OPM, in which the company remained private (the &#147;<B><I>Remain Private Scenario</I></B>&#148;), (ii) the IPO Scenario (as defined below) and (iii)&nbsp;a default scenario. The IPO
scenario was introduced for the April 2020 Valuation as the Company had engaged in discussions with investors in connection with the Series E Financing about the plan for an IPO in a time frame of approximately 26 months after the Series E Financing
(the &#147;<B><I>IPO Scenario</I></B>&#148;). The scenarios were weighted as follows: (i) 60% for the Remain Private Scenario, which was determined based on the implied value from the Series E Financing, (ii) 30% for the IPO Scenario occurring at 26
months after the Series E financing, which was valued using a guideline public company market approach, and (iii) 10% on the default scenario. The April 2020 Valuation applied a DLOM of 35% and 27% to the Remain Private Scenario and the IPO
Scenario, respectively, to reflect that the value of the ordinary shares was on a <FONT STYLE="white-space:nowrap">non-marketable</FONT> basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED BY </B><B>GLOBAL-E ONLINE LTD</B><B>.</B> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>March </B><B>12</B><B>, 2021</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Page </B><B>
4</B>
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g77487dsp02.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I><U>December 2020 Valuation </U> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A valuation was performed by the Company with the assistance of a third-party independent valuation firm that determined the fair value of the
Company&#146;s ordinary shares to be $2,435.39 per share as of December&nbsp;31, 2020 (the &#147;<B><I>December 2020 Valuation</I></B>&#148;). The December 2020 Valuation estimated the ordinary share value using a PWERM that considered (i)&nbsp;the
Remain Private Scenario using an OPM and (ii)&nbsp;the IPO scenario. The scenarios were weighted as follows: (i) 50% for the Remain Private Scenario, which was determined based on the implied value from the Series E Financing and (ii) 50% for the
IPO scenario, which was valued using a guideline public company market approach. The December 2020 Valuation further applied a DLOM of 35% and 27% to the Remain Private Scenario and the IPO Scenario, respectively, to reflect that the value of the
ordinary shares was on a <FONT STYLE="white-space:nowrap">non-marketable</FONT> basis. The primary reason for the increase in the fair market value per ordinary share in the December 2020 Valuation, as compared to the April 2020 Valuation, was the
Company&#146;s continued progress towards an IPO, as reflected by the increased weighting given to the IPO scenario. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I><U>October Grant
and December Grant</U> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the grants of share options made on October&nbsp;21, 2020 (the &#147;<B><I>October
Grant</I></B>&#148;) and December&nbsp;10, 2020 (the &#147;<B><I>December Grant</I></B>&#148;), the Company concluded that the fair value of the ordinary shares was $2,110.42 per share and $2,339.27 per share, respectively. For financial reporting
purposes, the Company considered the amount of time between the April 2020 Valuation and the October Grant and December Grant to determine whether, in each case, to use the latest ordinary share valuation determined pursuant to the methods described
above under the heading &#147;Analysis of Option Grants Since September&nbsp;1, 2020&#151;Ordinary Shares Valuation Methodologies,&#148; or a straight-line calculation between the April 2020 Valuation and December 2020 Valuation. The Company
determined that the straight-line calculation would provide the most reasonable conclusion for the valuation of the Company&#146;s ordinary shares on these interim grant dates between the April 2020 Valuation and December 2020 Valuation because
there was no single event that occurred during these periods that resulted in the increase in fair value but rather a series of events related to exceeding the Company&#146;s financial targets, as well as consideration of the Company&#146;s progress
toward a liquidity event, as the Company had submitted its draft Registration Statement in December 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED BY </B><B>GLOBAL-E ONLINE LTD</B><B>.</B> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>March </B><B>12</B><B>, 2021</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Page </B><B>
5</B>
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g77487dsp02.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Comparison Of December Grant Fair Value And Preliminary Assumed IPO Price </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As noted above, the Preliminary Price Range is between $[***] and $[***] per share, with a Preliminary Assumed IPO Price of approximately
$[***] (in each case, without giving effect to the contemplated Stock Split that the Company intends to effect prior to the Commission&#146;s declaration of effectiveness of the Registration Statement). The Company notes that, as is typical in IPOs,
the estimated price range for this offering was not derived using a formal determination of fair value, but was determined by negotiation between it and the lead underwriters. As noted above, the Company&#146;s Board of Directors determined the fair
value per ordinary share to be $2,339.27 (the &#147;<B><I>Estimated Fair Value</I></B>&#148;) in connection with the December Grant, and the fair value per ordinary share to be $2,435.39 in connection with the December 2020 Valuation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As is typical in IPOs, the Preliminary Price Range was based in part on the lead underwriters&#146; quantitative and qualitative analyses that
differ from the valuation methodology used by the Company. Among the factors that were considered in setting the Preliminary Price Range were the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an analysis of the typical valuation ranges seen in comparable public companies in the Company&#146;s industry,
as well as a broader set of valuation ranges seen in recent IPOs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the general condition of the securities markets and the recent market prices of publicly traded shares of
comparable companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">feedback received from potential investors in December 2020 through February 2021 from the Company&#146;s <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">testing-the-waters</FONT></FONT> meetings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an assumption that there would be a receptive public trading market for an
<FONT STYLE="white-space:nowrap">e-commerce</FONT> platform company such as the Company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an assumption that there would be sufficient demand for the Company&#146;s shares to support an offering of the
size contemplated by the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company respectfully submits that, in addition to the above factors, the
difference between the Estimated Fair Value and the Preliminary Assumed IPO Price is that the PWERM and OPM hybrid valuation methods used by the Company to determine the Estimated Fair Value reflect the potential that the Company might remain a
privately held company, which inherently decreases the Estimated Fair Value per share of the Company&#146;s ordinary shares due to the combination of: (i)&nbsp;the expected business equity value in the Remain Private Scenario that was significantly
lower than in the IPO Scenario; (ii)&nbsp;the discounting to present value from a prospective exit event; and (iii)&nbsp;the application of a discount for lack of marketability. Conversely, the Preliminary Assumed IPO Price assumes only a single
potential liquidity event, a successful IPO, which was not assured as of any valuation date (nor now), and does not include a discount for present value or a discount for lack of marketability, as an active trading market for the Company&#146;s
ordinary shares would exist following the IPO. As a result, the Preliminary Assumed IPO Price was neither reduced due to the expected business equity value from other potential outcomes nor discounted for lack of marketability. Additionally, the
Preliminary Assumed IPO Price assumes the conversion of all of the Company&#146;s convertible preferred stock into ordinary shares in connection with the completion of the IPO. The corresponding elimination of the preferences and rights enjoyed by
the holders of such convertible preferred stock results in a higher valuation of the ordinary shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED BY </B><B>GLOBAL-E ONLINE LTD</B><B>.</B> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>March </B><B>12</B><B>, 2021</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Page </B><B>
6</B>
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g77487dsp02.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In conclusion, the Company respectfully submits that the difference between the Estimated
Fair Value and the Preliminary Assumed IPO Price is reasonable. As requested by the Staff, the Company will continue to update its disclosure for all equity related transactions through the effective date of the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Company respectfully requests that the information contained in this request letter be treated as confidential information and that the
Commission provide timely notice to Amir Schlachet, Chief Executive Officer, <FONT STYLE="white-space:nowrap">Global-E</FONT> Online Ltd., 25 Basel Street, Petah Tikva 4951038, Israel, telephone <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">+972-73-2605078,</FONT></FONT> before it permits any disclosure of the bracketed and highlighted information contained in this Letter. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please direct any questions or comments regarding this letter or the Registration Statement to the undersigned at +44.20.7710.5820 or by fax
at +9.725.4621.8157. Thank you for your assistance. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joshua G. Kiernan</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joshua G. Kiernan, Esq.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">of LATHAM&nbsp;&amp;
WATKINS LLP</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amir Schlachet, <FONT STYLE="white-space:nowrap">Global-E</FONT> Online Ltd. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Oded</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Griffel, Esq., <FONT STYLE="white-space:nowrap">Global-E</FONT> Online Ltd. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Nathan</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ajiashvili, Esq., Latham&nbsp;&amp; Watkins LLP </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Mike</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Rimon, Esq., Meitar | Law Offices </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Shachar</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Hadar, Esq., Meitar | Law Offices </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">David</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">J. Goldschmidt, Esq., Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Yossi</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Vebman, Esq., Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Chaim</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Friedland, Esq., Gornitzky&nbsp;&amp; Co. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Ari</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fried, Esq., Gornitzky&nbsp;&amp; Co. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED BY </B><B>GLOBAL-E ONLINE LTD</B><B>.</B> </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g77487dsp01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g77487dsp01.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
/4 % !0 4 % !0 4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g77487dsp02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g77487dsp02.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( !0 N ,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /:[W6!9Z_IFE^3N-\DSB3=C9Y87MCG.[]*ERLTC:-+FI2J7
MVM^-_P#(TRV!FJ,3G?#'B^W\3R:DEO!Y8LIO+!WY\Q><-T& <'UK.%13;L=F
M*PDL-RW=[K[O(Q]1\>ZMI^KC3_\ A$YI&EDD2W87&/-"Y.0-GH,U+J-2M8VI
MX.E.GS^TM;R_X)KW'BJ2TN_#UK<:<T<VKDAE,G,!"@D=.>N.U4YV:5MSGCAU
M+G:E\/XEF?Q$L'BZTT#[,2UQ;M/YN_[N#C&,?UIN5I*),:'-1E5OLU^)2\5>
M-;;PK=:;!/!YIO)-I(?'EH" 7/!Z9'I2G44&DR\/A77C*2=K+_/0Z"ZNUM;&
M:Z896*-I#SU &:N^ESGC'FDHG/Z;XUM=1\$3>)?)\M(8Y'>'S,E2N?ESCOQV
M[U$9WAS'55P<J>(]@G<O^&_$$?B'P[;:NL/D),&RA?=MPQ!YP/2JC+F29CB*
M+H573WL6+_55M=$NM2MHQ="")I B-C?M!.,X/I3;LKDTZ;G4C3>EVD8NJ>.+
M72_#VDZN;?S$U%XU">9C8&&2V<<X_"LY5.5)G32P;J594[[)FD^O8\5Q:'':
MERUJ;EYM^ @W8 QCN?>KYO>Y3%4/W/M6^MBC)XRAC\<)X9-MRT>[S_,X#X+;
M,8ZX&>M3[1<_*:+"2>'=>_R*WB?QGJ'ARY8+X>EN[0; +@3;068X QM/<BE.
M;CLBL+A85UK.S[6_X)9E\575GX/N==O]'>UE@/-JTO)&X '=M]\]*IRM&[1"
MP\95O91E?SMY7+!\2F3Q3'HEI9&?;'ON9A)@0>@(QR3]11S^]9">'Y:7M).W
M;S)K+7UO/$NIZ,+?:;!(G,F_._>">F.,8]:%*\G$F=#DI1J7^*_X6*6A>,;;
M6M=U;2?)$%Q82F, R9,J@D%@,#'3WZU,:EY./8TK825*G"INI(DL/%UO=>%)
M]?GA^SP0&7<N_=]QBO7 ZX].]-3O'F%/"RC75!:O3\KCO#>OZCK8F>\T-].B
M"JT3/+N\P'/;:,=OSIPDY;JPL11ITG:,[OKI:WXFZ)5.W!'S=.>M6CEU&Q3Q
MS$B-U;'7!S0-IK<Y?Q!-%;^//#$DTB1H(;SYF; '$=9R:4U\SLHIO#5$N\?_
M &XM^*=;CL/"-_>VTHD)C,4)C(.9&^5>?J13E)*+L9X:DYUXQEMU.&T&2?PW
MXM\/6[:;<65M=68L)3*% DD0$JW!/.21^-8Q]R25MSU*T57H5)N7,T[KYVO^
M".MU\8\<^$O]^Y_]%&M)?%$\^A_ J>B_-&1\0[:>]\3^$;>VNFM)I)Y@LZ $
MH=HY -353;B;8"48PJN2OH5;#3+_ $KXK:;%?ZM+J4C6$K*\B!=@STXI<MJB
MU-:E6G4PDW"'+JNY#X@#>(O$7B&,:3<7B6]I_9\+Q;2(W(+LW)'.2H_"E-MM
MI(O#Q5&G3O)*[N_-:?Y,UCK_ -L^#EQJ#Y$ZV+V\@/42 >6?UJU*].YS.@HX
MWE3\_P!3EC;-I>J3>"BG[K5KFUF4#H8MH,OZQX_&L?A_=GI-J:^M+>-_ST_
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MY."3C6:?9_DR;XBC_BWNJXX^1/\ T-:57X&/+G_M,7Z_DRAX(F32]0U+0+X
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MEGL;2ZDADN+6&5X6WQM)&&*-ZC/0^XHLF"G**:3W%DM;>6>&>2WC>:')CD9
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MWFVWYCET^R6P^PK9P"SV;/($8\O;Z;>F/:CE5K6#GES<U]>XLEA9RVJ6LEI
M]LFW;$T8*+M^[@=!C QZ8HLF)3E%W3U'W%K;WEN]O<P1SP/]Z.1 RGZ@\4-7
MT81E*#O%V9&=.L3?+?&S@-VJ;%G\L;POH&ZX]J+):C<Y./+?3L.2SM8KJ6ZC
MMHDN)@!)*J ,X'3)ZG%%D)SDXJ+>B&C3K$03P"R@$-PS-,GE#;(3U+#')/?-
M%EL/GG=.^JV\A(=,T^WL?L,%C;Q6G/[A(E"<\GY0,4))*R"52<I<TFV^XEKI
G>GV4\D]I86UO+* )'BB56?'3) YHLEJ$JDY+EDVT6\#TID!0!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
